NCT04606407View on ClinicalTrials.gov

Inhaled NO for the Treatment of Viral Pneumonia in Adults

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

August 7, 2022

Study Completion Date

August 7, 2022

Conditions
Viral PneumoniaNitric OxideRespiratory DiseasePneumonia, ViralInhaled Nitric OxideCovid19SARS-CoV Infection
Interventions
DEVICE

LungFit™

Patients will receive inhalations of 150 ppm for 40 min 4 times a day, up to 7 days (maximum 28 treatments)

Trial Locations (3)

Unknown

Shaare Zedek Medical Center, Jerusalem

Hasharon Medical Center, Petah Tikva

Rabin Medical Center, Petah Tikva

Sponsors

Lead Sponsor

Beyond Air Inc.
All Listed Sponsors
lead

Beyond Air Inc.

INDUSTRY